What causes Polycystic Ovary Syndrome (PCOS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Polycystic Ovary Syndrome (PCOS)

Polycystic Ovary Syndrome (PCOS) is a highly heritable, complex endocrine disorder caused by a combination of genetic predisposition, hormonal imbalances, and environmental factors that lead to accelerated pulsatile gonadotropin-releasing hormone (GnRH) secretion, insulin resistance, and downstream metabolic dysregulation. 1

Pathophysiological Mechanisms

Hormonal Dysfunction

  • Hypothalamic-Pituitary-Ovarian Axis Abnormalities:

    • Accelerated GnRH pulse secretion leads to increased luteinizing hormone (LH) production 1
    • Elevated LH/FSH ratio (>2) is characteristic of PCOS 2
    • Hypersecretion of LH causes ovarian theca stromal cell hyperactivity 1
    • Hypofunction of the FSH-granulosa cell axis results in follicular arrest 1
  • Hyperandrogenism:

    • Increased androgen production from ovarian theca cells
    • Elevated testosterone levels (>2.5 nmol/l) 2
    • Elevated androstenedione levels (>10.0 nmol/l) 2
    • Clinical manifestations include hirsutism, acne, and male-pattern hair loss

Metabolic Dysfunction

  • Insulin Resistance and Hyperinsulinemia:

    • Present in up to 70% of women with PCOS, even in those with normal weight
    • Contributes to hyperandrogenism by stimulating ovarian androgen production
    • Decreases sex hormone-binding globulin (SHBG) production, increasing free testosterone
    • Glucose/insulin ratio <4 indicates insulin resistance 2
  • Obesity and Adipose Tissue Dysfunction:

    • Weight gain can trigger the development of PCOS in genetically predisposed individuals 1
    • Abdominal adiposity is common in PCOS and worsens metabolic and reproductive features 1
    • Adipose tissue dysfunction contributes to chronic low-grade inflammation

Genetic and Environmental Factors

Genetic Components

  • PCOS is highly heritable with a complex multigenic pattern 3
  • Multiple genes related to androgen synthesis, insulin action, and inflammation are implicated
  • Family history is a significant risk factor - first-degree relatives have increased risk

Environmental Influences

  • Lifestyle Factors:

    • Diet quality is often poorer in women with PCOS 1
    • Higher cholesterol intake (MD: 12.78 mg/day) 1
    • Lower magnesium and zinc intake 1
    • Lower total physical activity levels 1
    • These factors may exacerbate underlying genetic predisposition
  • Fetal Programming:

    • Exposure to excess androgens in utero may predispose to PCOS development 4
    • Maternal PCOS, obesity, or gestational diabetes may increase risk in offspring

Comorbid Conditions and Their Relationship to PCOS

  • Epilepsy Connection:

    • Higher prevalence of PCOS (10-25%) in women with temporal lobe epilepsy, even without antiepileptic drugs 1
    • Some antiepileptic drugs may affect sex hormone levels and trigger PCOS development
  • Cardiovascular and Metabolic Risk:

    • PCOS increases risk for metabolic syndrome, type 2 diabetes, and cardiovascular disease 1
    • Annual screening for these conditions is recommended 2

Diagnostic Considerations

  • Rotterdam Criteria typically used for diagnosis, requiring two of three:

    1. Oligo/anovulation
    2. Clinical or biochemical hyperandrogenism
    3. Polycystic ovaries on ultrasound (≥20 follicles per ovary and/or ovarian volume ≥10ml) 2
  • Laboratory Testing:

    • LH/FSH ratio >2 suggests PCOS 2
    • Elevated testosterone, androstenedione, and DHEAS levels 2
    • Fasting glucose/insulin ratio to assess insulin resistance 2

Clinical Implications

  • PCOS affects 5-18% of reproductive-aged women globally 1, 3
  • Presents with reproductive (irregular menses, infertility), metabolic (insulin resistance), and dermatological (hirsutism, acne) manifestations
  • Requires lifelong management as complications evolve from reproductive issues in younger years to metabolic complications later in life 4

Management Considerations

  • Lifestyle Modifications:

    • First-line approach, especially with excess body weight 2
    • Improving diet quality and increasing physical activity can improve symptoms
  • Pharmacological Approaches:

    • Hormonal therapy to regulate menstrual cycles and reduce androgen levels 2
    • Metformin for insulin resistance (starting at 500mg daily, increasing to 1500-2000mg) 2

Understanding the complex, multifactorial etiology of PCOS is essential for appropriate diagnosis and management of this common endocrine disorder that affects women throughout their lifespan.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Menstrual Irregularity Evaluation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Polycystic ovary syndrome throughout a woman's life.

Journal of assisted reproduction and genetics, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.